In this randomized clinical trial , 86 eyes with recent onset ( < 12 weeks ) CRVO were assigned to two groups : IVB group ( 43 eyes ) that received three monthly injections of 1.25 mg of IVB , and IVT group ( 43 eyes ) that received two injections of 2 mg IVT 2 months apart .